LeMaitre Q4 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Lemaitre Vascular (LMAT) Misses Q4 EPS by 3c
February 24, 2022 5:19 PM ESTLemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.28, $0.03 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.7 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2022 EPS of $0.26-$0.30, versus the consensus of $0.30.... More
